India Pesticides Ltd, one of the fastest growing agro-chemical companies for technical manufacturing, reported a 41% year-on-year rise in consolidated profit after tax (PAT) at Rs 31 crore for the March quarter of FY26, driven by strong demand for herbicides and intermediates across domestic markets.
The company’s revenue for Q4 FY26 rose 28.5% to Rs 271 crore compared with Rs 211 crore in the corresponding quarter of the previous fiscal. The strong quarterly performance was supported by healthy volume growth and improved operational efficiencies.
Technical and API segments drive growth
India Pesticides said its technical and API businesses contributed 71% of total revenue during the quarter, underlining the strength of its diversified product portfolio and manufacturing-led business model.
The company delivered robust operational performance during the quarter, supported by rising domestic demand and higher traction for herbicides and related intermediates.
FY26 revenue rises 27.9%
For the full year FY26, the company posted revenue of Rs 1,078 crore, registering a growth of 27.9% over Rs 843 crore in FY25.
EBITDA for the year increased 44.7% year-on-year to Rs 194 crore, while EBITDA margins improved to 18%. Annual PAT stood at Rs 120 crore, up 45.8% from Rs 82 crore in the previous fiscal.
The company said the growth was primarily driven by strong domestic demand, healthy volume expansion and better operational efficiencies.
Crosses Rs 1,000 crore revenue milestone
A major milestone during FY26 was India Pesticides crossing the Rs 1,000 crore revenue mark for the first time.
The company said the achievement reflects its expanding market presence, strong execution capabilities and focus on innovation-led manufacturing, supported by capacity expansion and backward integration initiatives.
Focus on innovation and expansion
Founder & Promoter Anand S Agarwal said the company’s R&D and project engineering capabilities continue to remain among its core strengths.
He said India Pesticides received multiple product registrations across Indian and international markets during the year, while in-house R&D efforts supported process innovation, cost optimisation and development of new molecules and intermediates.
The company plans to continue expanding its manufacturing capabilities, strengthen backward integration and deepen its presence in domestic and international markets. It also remains focused on improving manufacturing efficiency and expanding its differentiated product portfolio